Skip to Content

Sparfloxacin has been withdrawn from the U.S. market.so what is the main cause?

Responses (1)

robo 11 Aug 2009

Zagam (sparfloxacin) was approved in the United States in December 1996 and it was withdrawn from market just over four years later.

Safety issues concerning Zagam included some reports of QT prolongation and a 7.9% incidence of phototoxicity.

Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Similar Questions